Ascend Advanced Therapies
PrivateLast Round
Strategic
Nov 12, 2024
Total Funding Raised
$263.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ascend Advanced Therapies is a biotechnology company that provides contract development and manufacturing services for gene and cell therapy developers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ascend Advanced Therapies Comparables
Compare Ascend Advanced Therapies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Andelyn Biosciences | 90% | |
| Advanced Medicine Partners | 84% | |
| Ajinomoto Co. Inc | 81% |
Ascend Advanced Therapies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Nov 12, 2024 | ||||
| Series A | Mar 20, 2023 | ||||
| Seed | Jun 22, 2021 |
Key People
Founding team and executive leadership
Ascend Advanced Therapies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cathay Capital | Series A, Strategic |
| Deerfield Management | Series A, Strategic |
| EW Healthcare Partners | Strategic |
| Digitalis Ventures | Series A, Strategic |
| DCVC Bio | Series A, Strategic |
| 4BIO Capital | Series A, Strategic |
| Ajinomoto Co., Inc. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 38% MoM.
Ascend Advanced Therapies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ascend Advanced Therapies's valuation, stock price, and market status.
Is Ascend a public or private company?
Ascend is a private company.
What is the current stock price of Ascend?
Ascend is a private company with no public stock price. No recent secondary market data is available.
How much is Ascend worth (valuation)?
Valuation information for Ascend is not publicly available.
Can I buy Ascend stock?
Ascend shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ascend's last funding round?
Ascend's most recent funding round was Strategic on November 12, 2024.
Who are the main investors in Ascend?
Key investors in Ascend include EW Healthcare Partners, Monograph Capital, Abingworth.
Will Ascend IPO soon?
No public IPO plans have been announced for Ascend.
How can I track Ascend secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ascend's secondary market activity and sign up for updates.